Drug Profile
CEA cancer DNA vaccine - Genvax
Latest Information Update: 11 May 2010
Price :
$50
*
At a glance
- Originator Genvax
- Class Cancer vaccines; DNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 22 May 2007 Phase-I/II clinical trials in Solid tumours in United Kingdom (IM)